Try our corporate solution for free!
(212) 419-8286

COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020

In November 2020, COVID-19 vaccines from the Biontech/Pfizer cooperation and from Moderna showed very good results in phase III of clinical trials. Both sites reported nearly the exact same efficacy of around 95 percent. Pfizer and BioNTech will probably be able to produce larger amounts until year-end 2020 and also during 2021.

Comparison of the COVID-19 vaccines developed by BioNTech/Pfizer and Moderna as of November 2020

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

November 2020



Survey time period

as of November 2020

Supplementary notes

* BioNTech/Pfizer: 1 severe case out of 8; Moderna: 0 severe case out of 5.
** BioNTech/Pfizer: 9 severe cases out of 162; Moderna: 11 severe cases out of 95.
*** Maximum estimate for Moderna.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.